Bio Essence Appoints Xiying Zhang and Geoff Fellows as Independent Directors
Bitget2026/10/26 12:07- Bio Essence appointed Xiying (Thea) Zhang and Geoff Fellows as independent directors, effective October 19, 2026.
- The appointments expanded the board from three to five members, making it majority independent.
- Zhang, formerly a senior supply chain leader with Oasis Pharmaceutical, brings more than 15 years of medical device and pharmaceutical experience.
- Fellows, CEO of Embarcadero Accessible Multi-Family Office and formerly its operations and compliance chief, brings more than three decades of financial-sector experience.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Investors reportedly offering Anthropic allocation shares at premiums of up to 5% ahead of its IPO
According to reports, the trading firm JonesTrading is marketing up to $500 million worth of stock shares on behalf of some investors, at a 3% to 5% premium over the IPO issue price. This indicates that investors are already transferring their anticipated IPO allotted shares before the IPO is officially issued.
Nvidia continues to plummet, losing $430 billion in market value over two days, with Microsoft temporarily reclaiming the world's second place.
On Tuesday, Nvidia closed down 5.5%, a decline significantly greater than other major tech stocks, making it a key factor dragging down the tech sector's performance. During intraday trading on Tuesday, Microsoft's market capitalization briefly surpassed Nvidia, making it the world's second largest publicly traded company by market value. However, after Anthropic released its office suite, Microsoft's losses widened, causing it to fall behind Nvidia once again.
Updated: CoreWeave Raises Revenue Forecasts, AI Demand Unfazed by Growing Doubts
Crypto prices
More
